Finola E. Moore, PhD

Dr Finola Moore's long-standing interest in cell death led her to study various aspects of cancer. The seemingly simple evasion of cell death by tumor cells truly requires disruption of several normal processes of the cell. Dr Moore has worked on some of these processes in her research career, ranging from cell cycle, stem cell self-renewal, tumor cell invasion, and leukemia. Dr Moore received her PhD at Northwestern University in Chicago, studying the spindle assembly checkpoint and the related changes in cell shape that help tumor cells migrate and invade distal sites. She continues to study cancer in her present position as a post-doctoral fellow at Massachusetts General Hospital/Harvard Stem Cell Institute in Boston. Dr. Moore's research at MGH focuses on T cell acute lymphoblastic leukemia, using a zebrafish model to study relapse caused by leukemia propagating cell self-renewal. Her current projects now encompass the common pathways in hematopoiesis and leukemogenesis. Dr Moore has a passion for scientific outreach and policy; she believes a scientifically literate public will help scientists and clinicians make sound health decisions for individuals and larger society.